| Type: |
Conjugated Primary Antibody |
| Conjugated with: |
594, ALEXA FLUOR® |
| Host organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Protein/Peptide: |
GnRH-associated peptide I |
| Specificity: |
This antibody reacts specifically with GnRH-associated peptide I |
| Modification: |
No modification has been applied to this antibody |
| Modification site: |
None |
| Clonality: |
Polyclonal Antibody |
| Clone: |
Polyclonal Antibodies |
| Concentration: |
1ug per 1ul |
| Antigen Source: |
KLH conjugated synthetic peptide derived from human peptide I |
| Gene ID: |
2796 |
| Applications: |
IF(IHC-P) |
| Applications with corresponding dilutions: |
IF(IHC-P)(1:50-200) |
| Cross reactive species: |
Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens) |
| Cross Reactive Species details: |
However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species |
| Background information: |
Alternatively spliced transcript variants have been described for this gene, Jul 2012], LHRH stimulates the release of luteinizing and follicle stimulating hormones, Mutation in this gene are associated with hypogonadotropic hypogonadism, [provided by RefSeq, also known as gonadoliberin-1), and prolactin release-inhibiting factor (also known as GnRH-associated peptide 1), which are important for reproduction, The protein encoded by this gene is secreted and then cleaved to form the 10 aa luteinizing hormone-releasing hormone (LHRH |
| Purification method: |
Purified by Protein A |
| Storage: |
50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA |
| Excitation emission: |
590nm/617nm |
| Synonyms: |
GNRH, GNRH1, GON1_HUMAN, GRH, GnRH-I, GnRH-associated peptide 1, GnRH-associated peptide I, Gonadotropin-releasing hormone I, LH-RH I, LHRH, Luliberin I, Luteinizing hormone-releasing hormone I, Progonadoliberin I, Progonadoliberin-1, progonadoliberin-1 isoform 1 precursor, progonadoliberin-1 isoform 2 preproprotein, LHRH |
| Also known as: |
GnRH-associated peptide I Antibody |
| Other name: |
Anti-GnRH-associated peptide I |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody |
| Properties: |
For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
Alexa Fluor |
| Description: |
, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, consisting of 2 amino acids joined by a single peptide bond, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, Peptides short amino acid chains or epitopes or blocking antagonists |
| Gene target: |
GnRH-associated peptide I |
| Short name: |
Fluor 594, Anti-GnRH-associated peptide I |
| Technique: |
peptides, peptide |
| Label: |
ALEXA |
| Alternative name: |
ALEXA Fluor 594, antibody to-GnRH-associated short protein sequence I |
| Alternative technique: |
peptides |